Cargando…
Vaccine Production in Africa: A Feasible Business Model for Capacity Building and Sustainable New Vaccine Introduction
Africa has the highest incidence of mortality caused by infectious diseases, and remarkably does not have the capacity to manufacture vaccines that are essential to reduce mortality, improving life expectancy, and promoting economic growth. GAVI has significantly helped introduction of new vaccines...
Autores principales: | Makenga, Geofrey, Bonoli, Stefano, Montomoli, Emanuele, Carrier, Trent, Auerbach, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435488/ https://www.ncbi.nlm.nih.gov/pubmed/30949465 http://dx.doi.org/10.3389/fpubh.2019.00056 |
Ejemplares similares
-
COVID-19 vaccine development, production and regulatory oversight in African countries
por: Makenga, Geofrey, et al.
Publicado: (2022) -
Pathogenic signature of invasive non-typhoidal Salmonella in Africa: implications for vaccine development
por: Piccini, Giulia, et al.
Publicado: (2020) -
The business of sustainability: building industry cases for corporate sustainability
por: Steger, U
Publicado: (2004) -
Building sustainable neuroscience capacity in Africa: the role of non-profit organisations
por: Karikari, Thomas K., et al.
Publicado: (2015) -
Society Builds Sustainability in Africa
por: Tillett, Tanya
Publicado: (2007)